Norris Medicines Limited
BSE: NORRIS.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Vimal Dhirendra Shah
- Employees
- 45
- Headquarters
- Ankleshwar, India
- IPO year
- 2025
- Market cap
- ₹139.4M
- Website
- http://www.norrispharma.com
Loading NORRIS…
Loading profile data…Frequently asked questions about NORRIS
What does Norris Medicines Limited (NORRIS.BO) do?
Norris Medicines Ltd. engages in the manufacture of pharmaceuticals, medicinal chemical, and botanical products. Its products range include antibiotic range, anti inflammatory, anti emetic, nutrition, cough and cold, skin and allergy, anti malarial, diabetic, and cardiac. The company was founded in 1990 and is headquartered in Ankleshwar, India.
Where does NORRIS.BO trade?
Norris Medicines Limited (NORRIS.BO) trades on the Bombay Stock Exchange.
What sector is NORRIS.BO in?
Norris Medicines Limited (NORRIS.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Norris Medicines Limited?
Vimal Dhirendra Shah is the chief executive officer of Norris Medicines Limited (NORRIS.BO).
Where is Norris Medicines Limited headquartered?
Norris Medicines Limited is headquartered in India.
Does NORRIS.BO pay a dividend?
Norris Medicines Limited (NORRIS.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NORRIS.BO go public?
Norris Medicines Limited (NORRIS.BO) completed its initial public offering in 2025.